Fora Capital, LLC Myriad Genetics Inc Transaction History

Fora Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$29.97 - $36.66 $30,779 - $37,649	-1,027 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$25.39 - $32.61 $26,075 - $33,490	1,027 New	1,027 $31 Million
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $144,639 - $229,447	-7,261 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$12.16 - $19.77 $3,830 - $6,227	315 Added 4.53%	7,261 $143,000
Q3 2020 Nov 13, 2020	BUY	$11.25 - $14.75 $78,142 - $102,453	6,946 New	6,946 $91 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.